Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
boston blog main
clinical trials
life sciences
national blog main
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
andrew berens
avapritinib
blueprint medicines
boston top stories
cancer
deciphera pharmaceuticals
drugs
fda
gastrointestinal stromal tumor
gist
givosiran
gleevec
imatinib
onpattro
patisiran
paul matteis
regorafenib
ripretinib
rna interference
steve hoerter
stifel financial
stivarga
sunitinib
sutent
svb leerink
What
approval
2
×
drug
fda
medicine
2
×
seek
2
×
ago
alnylam
announced
blueprint
cancer
chasing
deadly
deciphera
filing
forms
gi
indicated
interference
morning
nod
pharamceuticals
pharmaceuticals
plans
quick
rna
rnai
second
speedy
treats
tumor
type
weeks
won’t
Language
unset
Current search:
approval
×
medicine
×
seek
×
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
